Checkpoint Days Of Inventory On Hand from 2010 to 2024
| CKPT Stock | USD 1.88 0.10 5.62% |
Days Of Inventory On Hand | First Reported 2010-12-31 | Previous Quarter 0.000008 | Current Value 0.000008 | Quarterly Volatility 0.00000543 |
Check Checkpoint Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Checkpoint main balance sheet or income statement drivers, such as Interest Income of 102.1 K, Depreciation And Amortization of 5.4 M or Interest Expense of 5.2 M, as well as many exotic indicators such as Price To Sales Ratio of 438, Dividend Yield of 0.0 or Days Sales Outstanding of 168. Checkpoint financial statements analysis is a perfect complement when working with Checkpoint Therapeutics Valuation or Volatility modules.
Checkpoint | Days Of Inventory On Hand |
Latest Checkpoint Therapeutics' Days Of Inventory On Hand Growth Pattern
Below is the plot of the Days Of Inventory On Hand of Checkpoint Therapeutics over the last few years. It is Checkpoint Therapeutics' Days Of Inventory On Hand historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Checkpoint Therapeutics' overall financial position and show how it may be relating to other accounts over time.
| Days Of Inventory On Hand | 10 Years Trend |
|
Days Of Inventory On Hand |
| Timeline |
Checkpoint Days Of Inventory On Hand Regression Statistics
| Arithmetic Mean | 0.000016 | |
| Geometric Mean | 0.000015 | |
| Coefficient Of Variation | 33.40 | |
| Mean Deviation | 0.00000458 | |
| Median | 0.000019 | |
| Standard Deviation | 0.00000543 | |
| Sample Variance | 0 | |
| Range | 0.0 | |
| R-Value | (0.71) | |
| Mean Square Error | 0 | |
| R-Squared | 0.51 | |
| Significance | 0 | |
| Slope | (0.00000086) | |
| Total Sum of Squares | 0 |
Checkpoint Days Of Inventory On Hand History
About Checkpoint Therapeutics Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Checkpoint Therapeutics income statement, its balance sheet, and the statement of cash flows. Checkpoint Therapeutics investors use historical funamental indicators, such as Checkpoint Therapeutics's Days Of Inventory On Hand, to determine how well the company is positioned to perform in the future. Although Checkpoint Therapeutics investors may use each financial statement separately, they are all related. The changes in Checkpoint Therapeutics's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Checkpoint Therapeutics's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Checkpoint Therapeutics Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Checkpoint Therapeutics. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 0.00000733 | 0.000008 |
Pair Trading with Checkpoint Therapeutics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Checkpoint Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Checkpoint Therapeutics will appreciate offsetting losses from the drop in the long position's value.Moving together with Checkpoint Stock
| 0.73 | EQ | Equillium Earnings Call This Week | PairCorr |
Moving against Checkpoint Stock
| 0.61 | ELYM | Eliem Therapeutics | PairCorr |
| 0.42 | MRK | Merck Company Financial Report 6th of August 2024 | PairCorr |
The ability to find closely correlated positions to Checkpoint Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Checkpoint Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Checkpoint Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Checkpoint Therapeutics to buy it.
The correlation of Checkpoint Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Checkpoint Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Checkpoint Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Checkpoint Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out the analysis of Checkpoint Therapeutics Correlation against competitors. For more information on how to buy Checkpoint Stock please use our How to Invest in Checkpoint Therapeutics guide.You can also try the Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.
Complementary Tools for Checkpoint Stock analysis
When running Checkpoint Therapeutics' price analysis, check to measure Checkpoint Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Checkpoint Therapeutics is operating at the current time. Most of Checkpoint Therapeutics' value examination focuses on studying past and present price action to predict the probability of Checkpoint Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Checkpoint Therapeutics' price. Additionally, you may evaluate how the addition of Checkpoint Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |
Is Checkpoint Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Checkpoint Therapeutics. If investors know Checkpoint will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Checkpoint Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.17) | Revenue Per Share 0.004 | Quarterly Revenue Growth (0.92) | Return On Assets (3.49) | Return On Equity (12.20) |
The market value of Checkpoint Therapeutics is measured differently than its book value, which is the value of Checkpoint that is recorded on the company's balance sheet. Investors also form their own opinion of Checkpoint Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Checkpoint Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Checkpoint Therapeutics' market value can be influenced by many factors that don't directly affect Checkpoint Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Checkpoint Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Checkpoint Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Checkpoint Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.